-
ASCO21 Recap: Immunotherapy’s Continued Progress and Addressing Healthcare Disparities
ASCO21 highlighted the latest immunotherapy advances in checkpoint inhibition and cell therapies, and addressed disparities in healthcare.
-
AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’
During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…
-
CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher
Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer
CRI highlights some of the many women who are and have been integral to our organization and…
-
Fuel for the Fight: How Cancer Metabolism Impacts the Immune System, with Dr. Greg Delgoffe
CRI Lloyd J. Old STAR Greg Delgoffe is exploring how cancer metabolism impacts the immune system and…
-
Cancer, COVID-19, and Vaccines: What Patients Need to Know
CRI experts share their latest insights on COVID-19 and cancer.
-
CRI-Funded Trial Highlights New Hope Against Pancreatic Cancer
New publication from the CRI PRINCE trial highlights benefits of an immunotherapy-chemotherapy combination against advanced pancreatic cancer.
-
Catching Up on Cancer Research with the CRI Anna-Maria Kellen Clinical Accelerator
Through a variety of efforts, the CRI Clinical Accelerator seeks to advance the next generation of immunotherapies…
